Skip to main content
Novartis Home

Language & Country Selector for Desktop

language-selector-globe Global | en

Choose Location

  • International
  • Americas
  • Europe
  • Middle East & Africa
  • Asia Pacific
  • Global | en
  • Sandoz | en
  • Novartis Foundation | en
  • Argentina | es
  • Brazil | pt
  • Canada | en
  • Canada | fr
  • Central America | es
  • Colombia | es
  • Mexico | es
  • United States | en
  • Venezuela | es
  • Austria | de
  • Belgium | fr
  • Belgium | nl
  • Bulgaria | bg
  • Czech Republic | cs
  • Czech Republic | en
  • Denmark | da
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Greece | el
  • Hungary | hu
  • Ireland | en
  • Italy | it
  • Latvia | lv
  • Lithuania | lt
  • Netherlands | nl
  • Norway | no
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Serbia | sr
  • Slovakia | sk
  • Spain | es
  • Sweden | sv
  • Switzerland | de
  • Switzerland | fr
  • United Kingdom | en
  • Egypt | en
  • Israel | he
  • South Africa | en
  • Turkey | tr
  • Australia | en
  • Bangladesh | en
  • Hong Kong S.A.R. | zh
  • India | en
  • Indonesia | en
  • Japan | ja
  • Korea | ko
  • Mainland China | zh
  • Malaysia | en
  • Pakistan | en
  • Philippines | en
  • Singapore | en
  • Taiwan | zh

Language & Country Selector for Mobile

language-selector-globe Global

Choose Location

International Americas Europe Middle East & Africa Asia Pacific
  • Argentina | es
  • Australia | en
  • Austria | de
  • Bangladesh | en
  • Belgium | fr
  • Belgium | nl
  • Brazil | pt
  • Bulgaria | bg
  • Canada | en
  • Canada | fr
  • Central America | es
  • Colombia | es
  • Czech Republic | cs
  • Czech Republic | en
  • Denmark | da
  • Egypt | en
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Greece | el
  • Hong Kong S.A.R. | zh
  • Hungary | hu
  • India | en
  • Indonesia | en
  • Ireland | en
  • Israel | he
  • Italy | it
  • Japan | ja
  • Korea | ko
  • Latvia | lv
  • Lithuania | lt
  • Mainland China | zh
  • Malaysia | en
  • Mexico | es
  • Netherlands | nl
  • Norway | no
  • Global | en
  • Sandoz | en
  • Novartis Foundation | en
  • Pakistan | en
  • Philippines | en
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Serbia | sr
  • Singapore | en
  • Slovakia | sk
  • South Africa | en
  • Spain | es
  • Sweden | sv
  • Switzerland | de
  • Switzerland | fr
  • Taiwan | zh
  • Turkey | tr
  • United Kingdom | en
  • United States | en
  • Venezuela | es
    • About
      • Board of Directors
        • Joerg Reinhardt
        • Simon Moroney
        • Nancy Andrews
        • Ton Buechner
        • Patrice Bula
        • Elizabeth Doherty
        • Ana de Pro Gonzalo
        • Bridgette Heller
        • Daniel Hochstrasser
        • Frans van Houten
        • Andreas von Planta
        • Charles Sawyers
        • William Winters
        • Charlotte Pamer-Wieser
      • Executive Committee
        • Vasant Narasimhan
        • Shreeram Aradhye
        • James Bradner
        • Victor Bulto
        • Karen Hale
        • Harry Kirsch
        • Rob Kowalski
        • Steffen Lang
        • Klaus Moosmayer
        • Richard Saynor
        • Marie-France Tschudin
        • Lutz Hegemann
        • Michael Willi
        • Kees Roks
      • Strategy
        • People and Culture
        • Data and Digital
      • Products
      • Innovative Medicines
      • Sandoz
      • Operations
        • Global Biotech Cooperations
      • Diversity & Inclusion
        • Equity
        • Diversity & Inclusion Governance and Community
        • Inclusivity
        • Parental Leave
        • Society
      • Quality
        • Audit program
        • Novartis Quality Management System (QMS)
        • Product and patient safety training
        • Regulatory inspections
        • Product recalls
        • Third-party suppliers
      About Novartis
    • Patients and Caregivers
      • Novartis Commitment to Patients and Caregivers
      • Diseases
      • Patient Organization Funding
      • Adverse Event Reporting
      • COVID-19: Patients and Caregivers
      • Stories: Patients Perspectives
      Patients & Caregivers
    • Healthcare Professionals
      • Medical Congresses and Events
        • Abstract summaries for EULAR
        • Abstract summaries for ACR
        • Abstract summaries for EADV
      • Products
      • Novartis Pipeline
      • Managed Access Programs
        • Novartis Gene Therapies Managed Access Program
      • Novartis External Funding
      • Healthcare Professional Resources by Country
      • Investigator-Initiated Trials / Studies
      • Transparency and Disclosure
      • Novartis Medical Information
        • Submit medical enquiry
      Healthcare Professionals
    • Research & Development
      • Novartis Institutes for BioMedical Research
        • Collaborations
        • NIBR Global Scholars Program
      • Technology Platforms
        • Radioligand Therapy
        • Gene Therapy
        • Cell Therapy
      • Research Disease Areas
        • Immuno-oncology research at Novartis
        • Oncology research at Novartis
        • Cardiovascular and metabolic disease research at Novartis
        • Autoimmunity, transplantation and inflammatory disease research at Novartis
        • Ophthalmology research at Novartis
        • Neuroscience Research at Novartis
        • Musculoskeletal Disease Research at Novartis
        • DAx: exploratory disease research at Novartis
      • Research Locations
        • Novartis Institute for Tropical Diseases
      • Novartis Pipeline
      • Translational Medicine
      • Research & Development Approach
      • Stories from our Labs
      • Open Source Science
      Research & Development
    • ESG
      • Access
        • Creating sustainable business models
        • Value-Based Pricing
        • Sub-Saharan Africa
        • Donations
        • Novartis Access Principles
        • Novartis Oncology Access
        • Patents and Licensing
      • Ethics, Risk and Compliance
        • Ethical Behavior
        • Compliance
        • Human Rights
        • Learning and Engagement
        • Risk management
      • Environmental Sustainability
        • Climate
        • Waste
        • Water
      • Global Health
        • Anti-Microbial Resistance (AMR)
        • Avoidable Blindness
        • Chagas Disease
        • Leprosy
        • Malaria
        • Sickle Cell Disease (SCD)
        • Novartis Foundation
      • Diversity & Inclusion
      • Reporting
        • Environmental, Social and Governance (ESG) Index
        • ESG Rating Performance
        • Codes, Policies and Guidelines
        • Materiality Assessment
        • Transparency and Disclosure
        • Targets
        • Positions
      Environmental, Social and Governance
    • Investors
      • Event Calendar
      • Financial Data
        • Novartis Annual Results
        • Novartis Quarterly Results
        • Novartis SEC Filings
        • Product Sales
        • Fixed-Income Securities
        • Expected Currency Impact
      • Share Data & Analysis
        • Share Monitor
        • Dividend Information
        • Share Ownership
        • Share Overview
      • Shareholder Information
        • General Meetings
        • American Depository Receipts (ADR)
        • Share Buy-Back
        • Frequently Asked Questions
      • Company Overview
        • Corporate Governance
      • Novartis Annual Reporting Suite
        • Reporting Archive
        • Publications Order Form
      • ESG
      Investors
    • News
      • News Archive
      • Media Library
      • Stories
      • Subscribe
      News
    • Careers
      • Career Search
      • Our Teams
        • Careers in Commercial
        • Careers in Communications and Advocacy
        • Careers in Consulting
        • Careers in Digital
        • Careers in Health, Safety & Environment
        • Careers in Information Technology (IT)
        • Careers in Medical & Development
        • Careers in People & Organization
        • Careers in Procurement
        • Careers in Research
        • Careers in Strategy
        • Careers in Manufacturing and Supply
        • Ethics, Risk & Compliance (ERC)
        • Careers in Legal
      • Career Programs
        • Community Exploration & Learning Lab (CELL)
      • Early Talent
      • Postdoc Program
        • Andreas Bender, PhD
        • Boxun Lu, PhD
        • The Novartis Innovation Postdoctoral Fellowship
        • The Novartis Discovery Postdoctoral Fellowship
        • Postdoc Research Themes
        • Recognition
        • Postdoc Program Leadership
      • International Careers
      • Learning and Development
      • Well-being
      • Internship Programs
      Careers
    • COVID-19 Information Center
      COVID-19 Novartis response
    • Clinical Trials
      Clinical Trials
    • Partnering
      Partnering
    • Contacts
      Contacts
    Home
  1. Home
  2. Careers
  3. Career Search
  4. Career Search
  • Sort by Sort ascending
  • Job Title
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date
Job Title Site Location Division Business Functional Area Date
Head of Supply Chain Management, NTO, LMMP, Sasayama 全国 Japan Novartis Technical Operations NTO OPHTHALMOLOGY LOCAL MARKET Jun 23, 2022
タクティカルプランナー 全国 Japan Novartis Technical Operations NTO OPHTHALMOLOGY LOCAL MARKET Jun 23, 2022
グループマネージャー MST ヘッド 篠山 Japan Novartis Technical Operations NTO OPHTHALMOLOGY LOCAL MARKET Jun 23, 2022
Manager, Commercial GMP QA Tokyo Japan Novartis Technical Operations NTO QUALITY Quality Jun 21, 2022
Associate, Quality Operations and Compliance Tokyo Japan Novartis Technical Operations NTO QUALITY Quality Jun 21, 2022
Technical Trainer, Sasayama 全国 Japan Novartis Technical Operations NTO OPHTHALMOLOGY LOCAL MARKET Jun 21, 2022
Japan Clinical Trial Lead Tokyo Japan NIBR TCO NIBR Research & Development Jun 21, 2022
Associate, Senior Clinical Data Manager 東京 Japan Global Drug Development GDO GDD Jun 16, 2022
Manager, Ethics, Risk & Compliance Tokyo Japan SANDOZ Commercial OPS SIR SZ Legal & Intellectual Property & Compl. Jun 07, 2022
Japan Program Head Tokyo Japan Global Drug Development IHD DU GDD Research & Development Jun 06, 2022
Associate, JCDM Tokyo Japan Global Drug Development CD&A GDD Research & Development Jun 03, 2022
Manager, Quality Operations and Compliance Tokyo Japan Novartis Technical Operations NTO QUALITY Quality Jun 02, 2022
Clinical Scientist Tokyo Japan NIBR Translational Medicine Research & Development Jun 02, 2022
Principal Scientist, Translational Medicine Japan Tokyo Japan NIBR Translational Medicine Research & Development Jun 02, 2022
Associate, GPRM Japan Tokyo Japan Global Drug Development REG AFFAIRS GDD Research & Development Jun 02, 2022
Head, Commercial Operations QA Division Tokyo Japan Novartis Technical Operations NTO QUALITY Quality Jun 02, 2022
Japan Program Manager Tokyo Japan Global Drug Development PORTFOLIO STRATEGY & MGMT GDD Research & Development Jun 02, 2022
Group Manager, Portfolio & Product Life Cycle Mgmt. 東京 Japan SANDOZ Commercial OPS SIR SZ May 26, 2022
Sales Execution Manager, Oncology Bio BU 東京 Japan SANDOZ Commercial OPS SIR SZ Sales May 26, 2022
Customer Service, B2B Business Lead 東京 Japan SANDOZ Commercial OPS SIR SZ May 26, 2022
Senior Associate, Biosimilar Development , Sandoz Tokyo Japan SANDOZ Commercial OPS SIR SZ Research & Development May 26, 2022
Order Management Operator, Sandoz Tokyo Japan SANDOZ Commercial OPS SIR SZ Technical Operations May 26, 2022
Head of Procurement Japan Tokyo Japan CTS PROCUREMENT NBS Procurement May 24, 2022
Japan Clinical Trial Lead Tokyo Japan NIBR TCO NIBR Research & Development May 24, 2022
Manager, Wholesalers 東京 Japan SANDOZ Commercial OPS SIR SZ Sales May 20, 2022
Lead Consultant – Management Consulting Tokyo Japan CTS NBS CONEXTS BD&L & Strategic Planning May 19, 2022
Group Manager, Rewards Management Tokyo Japan CTS HR NBS Human Resources May 19, 2022
Associate, PV Compliance &Process Tokyo Japan Global Drug Development CMO & PATIENT SAFETY GDD Research & Development May 18, 2022
Manager or Associate , External Communications Tokyo Japan CTS COMMS & ENGAGEMENT Communications & Public Affairs Apr 27, 2022
Head, Portfolio, BD&L and Launches Japan Tokyo Japan SANDOZ Commercial OPS SIR SZ BD&L & Strategic Planning Apr 13, 2022
Medical Affairs Associate (BIO,ONC), Sandoz Japan Nationwide Japan SANDOZ Commercial OPS SIR SZ Research & Development Apr 07, 2022
Clinical Senior Associate, Biosimilar Statistics, Sandoz Tokyo Japan SANDOZ Commercial OPS SIR SZ Research & Development Apr 07, 2022
Associate, Tokai Area, Sandoz Tokai Japan SANDOZ Commercial OPS SIR SZ Sales Apr 06, 2022
Senior Biostatistician Tokyo Japan Global Drug Development CD&A GDD Research & Development Apr 05, 2022
Group Manager, QC 篠山 Japan Novartis Technical Operations NTO QUALITY Mar 30, 2022
Associate, CRA Tokyo Japan Global Drug Development GDO GDD Research & Development Mar 28, 2022
Local Master Data Management, Sandoz Tokyo Japan Novartis Technical Operations NTO SANDOZ TECHOPS Technical Operations Mar 25, 2022
Head, Product QA Tokyo Japan Novartis Technical Operations NTO QUALITY Quality Mar 24, 2022
Manager, Distribution Center Management, Sandoz Tokyo Japan Novartis Technical Operations NTO SANDOZ TECHOPS Technical Operations Mar 22, 2022
Senior Dev QA Specialist 全国 Japan Global Drug Development QA GDD Mar 17, 2022
Associate, Site Finance , Sasayama, Japan Sasayama Japan Novartis Technical Operations NTO LOCAL MARKET MANUFACTURING Audit & Finance Mar 03, 2022
Associate, Lifecycle Manager ,Sasayama Sasayama Japan Novartis Technical Operations NTO LOCAL MARKET MANUFACTURING Technical Operations Jan 13, 2022
Project Engineer ,Sasayama Sasayama Japan Novartis Technical Operations NTO LOCAL MARKET MANUFACTURING Technical Operations Dec 20, 2021
Japan Program Head 東京 Japan Global Drug Development IHD DU GDD Dec 14, 2021
Associate, Process Engineer,Sasayama Sasayama Japan Novartis Technical Operations NTO LOCAL MARKET MANUFACTURING Technical Operations Nov 03, 2021
Site Project Manager ,Sasayama Sasayama Japan Novartis Technical Operations NTO LOCAL MARKET MANUFACTURING Technical Operations Oct 14, 2021
Regulatory Affairs Manager or Associate, Sasayama Sasayama Japan Novartis Technical Operations NTO QUALITY Quality Sep 05, 2021

Novartis

Navigate Novartis
  • Patients and Caregivers
  • Healthcare Professionals
  • Researchers
  • Job Seekers
  • Journalists
  • Investors
  • Partners
  • Suppliers
Topics
  • Clinical Trials
  • COVID-19 Info Center
  • ESG
Explore
  • Stories
  • Diseases
  • Locations
  • Products
  • Novartis Pipeline
Novartis companies
  • Sandoz
  • Advanced Accelerator Applications
  • Gyroscope Therapeutics
Footer Bottom
© 2022 Novartis AG
  • Terms of Use
  • Privacy
  • Contacts
  • Cookie Settings
  • Site Map
  • Web Accessibility
  • Open Source
Novartis Site Directory
This site is intended for a global audience